Oral formulation strategies to improve solubility of poorly water-soluble drugs

Bibliography

• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29(3-4):278-87
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004;113(1-3):151-70
   PubMed Web of Science ®Google Scholar
• Noyes AA, Whitney WR. The Rate of Solution of Solid Substances in their own Solutions. J Am Chem Soc 1897;19(12):930-4
   Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60(9):1281-302
   PubMed Web of Science ®Google Scholar
• Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol 2009;61(12):1571-86
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14(12):1691-8
   PubMed Web of Science ®Google Scholar
• Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131-44
   PubMed Web of Science ®Google Scholar
• Hilton JE, Summers M. The effect of wetting agents on the dissolution of indomethacin solid dispersion systems. Int J Pharm 1986;31(1-2):157-64
   Web of Science ®Google Scholar
• Usui F, Maeda K, Kusai A, Inhibitory effects of water-soluble polymers on precipitation of RS-8359. Int J Pharm 1997;154(1):59-66
   Web of Science ®Google Scholar
• Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull (Tokyo) 1961;9(11):866-72
   Web of Science ®Google Scholar
• Tachibana T, Nakamura A. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: dispersion of beta-carotene by polyvinylpyrrolidone. Colloid Polym Sci 1965;203(2):130-3
   Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88(10):1058-66
   PubMed Web of Science ®Google Scholar
• Villiers A. Sur la fermentation de la fecule par l'action du ferment butyrique. Compt Rend Acad Sci 1891;112:536-8
   Google Scholar
• Avdeef A, Bendels S, Tsinman O, Solubility-excipient classification gradient maps. Pharm Res 2007;24(3):530-45
   PubMed Web of Science ®Google Scholar
• Kim CK, Park JS. Solubility enhancers for oral drug delivery: can chemical structure manipulation be avoided? Am J Drug Deliv 2004;2(2):113-30
   Google Scholar
• Loftsson T, Jarho P, Masson M, Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2(2):335-51
   PubMedGoogle Scholar
• Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61(3):115-25
   PubMed Web of Science ®Google Scholar
• Lantz AW, Rodriguez MA, Wetterer SM, Estimation of association constants between oral malodor components and various native and derivatized cyclodextrins. Anal Chim Acta 2006;557(1-2):184-90
   Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85(10):1017-25
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-66
   PubMed Web of Science ®Google Scholar
• Valle EMMD. Cyclodextrins and their uses: a review. Process Biochem 2004;39(9):1033-46
   Web of Science ®Google Scholar
• Nagase Y, Hirata M, Wada K, Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether [beta]-cyclodextrin. Int J Pharm 2001;229(1-2):163-72
   PubMed Web of Science ®Google Scholar
• Zarzycki P, Lamparczyk H. The equilibrium constant of [beta]-cyclodextrin-phenolphtalein complex; influence of temperature and tetrahydrofuran addition. J Pharm Biomed Anal 1998;18(1-2):165-70
   PubMed Web of Science ®Google Scholar
• Cappello B, Carmignani C, Iervolino M, Solubilization of tropicamide by hydroxypropyl-[beta]-cyclodextrin and water-soluble polymers: in vitro/in vivo studies. Int J Pharm 2001;213(1-2):75-81
   PubMed Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007;123(2):78-99
   PubMed Web of Science ®Google Scholar
• Szejtli J. Medicinal applications of cyclodextrins. Med Res Rev 1994;14(3):353-86
   PubMed Web of Science ®Google Scholar
• Bekers O, Uijtendaal E, Beijnen J, Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 1991;17(11):1503-49
   Web of Science ®Google Scholar
• Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329(1-2):1-11
   PubMed Web of Science ®Google Scholar
• Pitha J, Milecki J, Fales H, Hydroxypropyl-[beta]-cyclodextrin: preparation and characterization; effects on solubility of drugs. Int J Pharm 1986;29(1):73-82
   Web of Science ®Google Scholar
• Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1-11
   PubMed Web of Science ®Google Scholar
• Liu L, Guo QX. The driving forces in the inclusion complexation of cyclodextrins. J Inclusion Phenom Macrocyclic Chem 2002;42(1):1-14
   Web of Science ®Google Scholar
• Dressman J, Butler J, Hempenstall J, The BCS: where do we go from here? Pharm Technol 2001;25(7):68-77
   Google Scholar
• Stella VJ, Rao VM, Zannou EA, Mechanisms of drug release from cyclodextrin complexes. Adv Drug Deliv Rev 1999;36(1):3-16
   PubMed Web of Science ®Google Scholar
• Jansook P, Kurkov SV, Loftsson T. Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci 2010;99(2):719-29
   PubMed Web of Science ®Google Scholar
• Thi TD, Nauwelaerts K, Baudemprez L, Comparison between 2-hydroxypropyl-beta-cyclodextrin and 2-hydroxypropyl-gamma-cyclodextrin for inclusion complex formation with danazol. J Inclusion Phenom Macrocyclic Chem 2011; published online 25 January 2011; doi: DOI 10.1007/s10847-010-9917-y
   PubMed Web of Science ®Google Scholar
• Rao VM, Sanghvi R, Zhu HJ. Solubility of pharmaceutical solids. 1st edition. Elsevier; San Diego: 2009
   Google Scholar
• Pitha J, Hoshino T, Torres-Labandeira J, Preparation of drug: hydroxypropylcyclodextrin complexes by a method using ethanol or aqueous ammonium hydroxide as co-solubilizers. Int J Pharm 1992;80(1-3):253-8
   Web of Science ®Google Scholar
• Pitha J, Hoshino T. Effects of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orange. Int J Pharm 1992;80(1-3):243-51
   Web of Science ®Google Scholar
• Miller LA, Carrier RL, Ahmed I. Practical considerations in development of solid dosage forms that contain cyclodextrin. J Pharm Sci 2007;96:1691-707
   PubMed Web of Science ®Google Scholar
• Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007;59(7):667-76
   PubMed Web of Science ®Google Scholar
• Porter CJH, Pouton CW, Cuine JF, Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 2008;60(6):673-91
   PubMed Web of Science ®Google Scholar
• Morozowich W, Gao P. Improving the oral absorption of poorly soluble drugs using SEDDS and S-SEDDS formulations. In Qiu Y, Chen Y, Liu L, Zhang GGZ. editors. Developing solid oral dosage forms: pharmaceutical theory and practice. 1st edition. Elsevier: San Diego, CA 2009. p. 443-50
   Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 2000;11:S93-8
   PubMed Web of Science ®Google Scholar
• Kossena GA, Charman WN, Wilson CG, Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharm Res 2007;24(11):2084-96
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60(6):625-37
   PubMed Web of Science ®Google Scholar
• Naylor LJ, Bakatselou V, Dressman JB. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res 1993;10(6):865-70
   PubMed Web of Science ®Google Scholar
• Dangi J, Vyas S, Dixit V. The role of mixed micelles in drug delivery. I. Solubilization. Drug Dev Ind Pharm 1998;24(7):681-4
   PubMed Web of Science ®Google Scholar
• Pedersen BL, Mullertz A, Brøndsted H, A comparison of the solubility of danazol in human and simulated gastrointestinal fluids. Pharm Res 2000;17(7):891-4
   PubMed Web of Science ®Google Scholar
• Wiedmann TS, Kamel L. Examination of the solubilization of drugs by bile salt micelles. J Pharm Sci 2002;91(8):1743-64
   PubMed Web of Science ®Google Scholar
• Volpenhein R, Webb D, Jandacek R. Effect of a nonabsorbable lipid, sucrose polyester, on the absorption of DDT by the rat. J Toxicol Environ Health 1980;6:679-83
   Web of Science ®Google Scholar
• Rozman K, Ballhorn L, Rozman T. Mineral oil in the diet enhances fecal excretion of DDT in the rhesus monkey. Drug Chem Toxicol 1983;6(3):311-16
   PubMed Web of Science ®Google Scholar
• Hauss D. Oral lipid-based formulations: enhancing the bioavailability of poorly water soluble drugs. Informa Healthcare, Inc; New York: 2007
   Google Scholar
• Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev 2008;60(6):734-46
   PubMed Web of Science ®Google Scholar
• Tang B, Cheng G, Gu JC, Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today 2008;13(13-14):606-12
   PubMed Web of Science ®Google Scholar
• Junghanns JUAH, Muller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008;3(3):295-310
   PubMed Web of Science ®Google Scholar
• Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 2006;62(1):3-16
   PubMed Web of Science ®Google Scholar
• Shegokar R, Muller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129-39
   PubMed Web of Science ®Google Scholar
• Simonelli A, Mehta S, Higuchi W. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. J Pharm Sci 1970;59(5):633-8
   PubMed Web of Science ®Google Scholar
• List M, Sucker H. Pharmaceutical colloidal hydrosols for injection. GB2200048; 1988
   Google Scholar
• Gassmann P, List M, Schweitzer A, Hydrosols: alternatives for the parenteral application of poorly water soluble drugs. Eur J Pharm Biopharm 1994;40(2):64-72
   Web of Science ®Google Scholar
• Sucker H, Gassmann P. Improvements in pharmaceutical compositions. GB2269536A; 1994
   Google Scholar
• Auweter H, Bohn H, Heger R, Precipitated water-insoluble colorants in colloid disperse form. US6494924; 2002
   Google Scholar
• Moschwitzer J. Method for the production of ultrafine submicron suspensions. DE1020050117864; 2005
   Google Scholar
• Moschwitzer J, Lemke A. Method for the gentle production of ultrafine particle suspensions. DE1020050177778; 2005
   Google Scholar
• Petersen R. Nanocrystals for use in topical cosmetic formulations and method of production thereof. WO2008058755; 2008
   Google Scholar
• Gonzales-Caballero F, de Dios Garcia Lopez-Duran J. Suspension formulation. Marcel Dekker, Inc; New York: 2000
   Google Scholar
• Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev 2011;63(6):427-40
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364(1):64-75
   PubMed Web of Science ®Google Scholar
• Manzano M, Vallet-Regi MA. New developments in ordered mesoporous materials for drug delivery. J Mater Chem 2010;20:5593-604
   Web of Science ®Google Scholar
• Colilla M, Manzano M, Vallet-Regi M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomedicine 2008;3(4):403
   PubMed Web of Science ®Google Scholar
• Yiu HHP, Botting CH, Botting NP, Size selective protein adsorption on thiol-functionalised SBA-15 mesoporous molecular sieve. Phys Chem Chem Phys 2001;3(15):2983-5
   Web of Science ®Google Scholar
• Qu F, Zhu G, Huang S, Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater 2006;92(1-3):1-9
   Web of Science ®Google Scholar
• Balas F, Manzano M, Horcajada P, Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 2006;128(25):8116-17
   PubMed Web of Science ®Google Scholar
• Schmidt-Winkel P, Lukens Jr WW, Zhao D, Mesocellular siliceous foams with uniformly sized cells and windows. J Am Chem Soc 1999;121(1):254-5
   Web of Science ®Google Scholar
• Charnay C, Begu S, Tourne-Peteilh C, Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm 2004;57(3):533-40
   PubMed Web of Science ®Google Scholar
• Horcajada P, Ramila A, Perez-Pariente J, Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 2004;68(1-3):105-9
   Web of Science ®Google Scholar
• Mellaerts R, Aerts CA, Van Humbeeck J, Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun 2007(13):1375-7
   PubMed Web of Science ®Google Scholar
• Grun M, Unger KK, Matsumoto A, Novel pathways for the preparation of mesoporous MCM-41 materials: control of porosity and morphology. Microporous Mesoporous Mater 1999;27(2-3):207-16
   Google Scholar
• Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005;21(21):9568-75
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Linden M. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J Control Release 2008;128(2):157-64
   PubMed Web of Science ®Google Scholar
• Mellaerts R, Mols R, Kayaert P, Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport. Int J Pharm 2008;357(1-2):169-79
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52(12):1145-9
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15(1):25-35
   Web of Science ®Google Scholar
• Mellaerts R, Jammaer JAG, Van Speybroeck M, Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: A case study with itraconazole and ibuprofen. Langmuir 2008;24(16):8651-9
   PubMed Web of Science ®Google Scholar
• Vialpando M, Aerts A, Persoons J, Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release. J Pharm Sci 2011; published online 8 March 2011; doi:10.1002/jps.22535
   PubMed Web of Science ®Google Scholar
• Kawabata Y, Yamamoto K, Debari K, Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability. Eur J Pharm Sci 2010;39(4):256-62
   PubMed Web of Science ®Google Scholar
• Onoue S, Sato H, Ogawa K, Improved dissolution and pharmacokinetic behavior of Cyclosporine A using high-energy amorphous solid dispersion approach. Int J Pharm 2010;399:94-101
   PubMed Web of Science ®Google Scholar
• Xie Y, Xie P, Song X, Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics. Int J Pharm 2008;360(1-2):53-7
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343(1-2):228-37
   PubMed Web of Science ®Google Scholar
• Pathak SM, Musmade P, Dengle S, Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation. Eur J Pharm Sci 2010;41:440-51
   PubMed Web of Science ®Google Scholar
• Tokumura T, Muraoka A, Machida Y. Improvement of oral bioavailability of flurbiprofen from flurbiprofen/[beta]-cyclodextrin inclusion complex by action of cinnarizine. Eur J Pharm Biopharm 2009;73(1):202-4
   PubMed Web of Science ®Google Scholar
• Wempe MF, Wacher VJ, Ruble KM, Pharmacokinetics of raloxifene in male Wistar-Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin. Int J Pharm 2008;346(1-2):25-37
   PubMed Web of Science ®Google Scholar
• Tan A, Simovic S, Davey AK, Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release 2009;134(1):62-70
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009;374(1-2):66-72
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009;72(3):539-45
   PubMed Web of Science ®Google Scholar
• Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci 2008;35(4):257-63
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun J, Wang Y, Solid self-emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation. Int J Pharm 2010;383(1-2):1-6
   PubMed Web of Science ®Google Scholar
• Onoue S, Takahashi H, Kawabata Y, Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 2010;99(4):1871-81
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 2010;40:325-34
   PubMed Web of Science ®Google Scholar